Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Armata Pharmaceuticals, Inc. (ARMP)

$3.64 +5.51% NYSE: ARMP · 15-min delayed
  • LOS ANGELES, California
  • Public · NYSE: ARMP
  • 61 employees
$171.1MMarket cap
-$173.8MNet income
61Employees
ARMPNYSE
1994IPO

About Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Net income
-$173.8M
Total assets
$76.9M
Market cap
$171.1M

Source: SEC EDGAR · updated Jun 7, 2026

NYSE: ARMP
$3.64 +5.51%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$2.78 $14.80

52-week range

Market cap
$171.1M
Shares outstanding
47.0M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
May 27, 1994

Armata Pharmaceuticals, Inc. (ARMP) Stock Price

  • Reported a net loss of $173.8M.
  • Trading 75% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Armata Pharmaceuticals, Inc..

Write a review
Newsroom

News about Armata Pharmaceuticals, Inc.

News & sentiment via Polygon.io

FAQ

Armata Pharmaceuticals, Inc.: frequently asked questions

Is Armata Pharmaceuticals, Inc. an American company?

Armata Pharmaceuticals, Inc. is a US-based company headquartered in Los Angeles, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Armata Pharmaceuticals, Inc. headquartered?

Armata Pharmaceuticals, Inc. is headquartered in Los Angeles, California, United States.

Is Armata Pharmaceuticals, Inc. publicly traded?

Yes — Armata Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol ARMP on the NYSE.

What does Armata Pharmaceuticals, Inc. do?

Armata Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →